Medicines, Poisons and Therapeutic Goods Regulation 2026
73Restriction on administration of certain Schedule 4 and 8 substances
Start here
Get a plain-English read of 73
Turn the raw legal text into a practical explanation grounded in Medicines, Poisons and Therapeutic Goods Regulation 2026.
73 Restriction on administration of certain Schedule 4 and 8 substances
73 Restriction on administration of certain Schedule 4 and 8 substances
(1) An authorised practitioner, other than a veterinary practitioner, must not administer the following to a person—
(a) a nominated Schedule 4 substance,
(b) a Schedule 8 substance if the person has a substance dependence on a prohibited scheduled substance or prohibited drug,
(c) dexamfetamine, lisdexamfetamine or methylphenidate,
(d) N,?-dimethyl-3,4-(methylenedioxy)phenylethylamine (MDMA) or psilocybine,
(e) morphine, oxycodone, fentanyl or hydromorphone in an amount that exceeds the morphine equivalent maximum dose,
(f) a substance (a relevant substance) that is alprazolam, flunitrazepam, methadone or a Schedule 8 substance in an injectable or intranasal preparation, if the administration is for a period that, together with all other periods for which a relevant substance has been administered by the person or has, to the person’s knowledge, been administered by another person, would result in one or more relevant substances being administered for continuous therapeutic use by the patient for more than 3 months.
Maximum penalty—Tier 5 penalty.
Note—
A health practitioner may be subject to other restrictions on the administration of scheduled substances under the Health Practitioner Regulation National Law in relation to appropriate professional conduct and practice.
(2) A veterinary practitioner must not administer the following—
(a) dexamfetamine or lisdexamfetamine,
(b) N,?-dimethyl-3,4-(methylenedioxy)phenylethylamine (MDMA) or psilocybine.
Maximum penalty—Tier 5 penalty.
(3) Subsection (1)(b) does not apply to a dentist.
(4) Subsection (1) does not apply to a person who administers the substance in accordance with an approval, approval exemption or OTP registration.